Global Insulin Delivery Devices Market Professional Survey Report 2019

Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.
On the basis of end user, the patients/homecare segment commanded the largest share of the insulin delivery devices market in 2017, and is expected to grow at the highest CAGR during the forecast period.
In 2017, North America accounted for the largest share of the global insulin delivery devices market. The large share of this segment can be attributed to the rising prevalence of diabetes and favorable reimbursement scenario in the U.S. and Canada, growing venture capital investments and issuance of IPOs in the U.S., and FDA approvals to increase the commercial availability of insulin delivery devices in the U.S.

The global Insulin Delivery Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Insulin Delivery Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Delivery Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Delivery Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Insulin Delivery Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Animas
Beta Bionics
Cellnovo
Copernicus
Dance Biopharm
Debiotech
Insulet
MannKind
Owen Mumford
Roche
SOOIL
Tandem Diabetes Care
Valeritas
West Pharma
Ypsomed

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Insulin Pens
Insulin Pumps
Insulin Syringes
Others

Segment by Application
Patients/Homecare
Hospitals & Clinics